Dr. Mark Biro, MD

Dr. Biro practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Biro's NPI, 1518464155, was assigned on April 10, 2018. Dr. Biro holds Illinois license 036170992.

Dr. Biro's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Biro's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Biro is also affiliated with University of Chicago Medical Center. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Biro to 2 more clinical labs and 2 medical groups, each named with a free account. Dr. Biro's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Biro practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Biro's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Biro is licensed in Illinois.

CMS data shows 57 Medicare services from Dr. Biro across 3 procedure codes in 2024, for 66 Medicare patients. Medicare paid $12,408 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 66 Medicare patients who saw Dr. Biro in 2024. The largest group is 75 to 84, with 31 patients. 70% of them have high blood pressure, and 68% have high cholesterol. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Biro's median patient age at 69, with 43% women.

In 2024, Dr. Biro wrote 191 Medicare Part D claims for 139 patients. 95% of them were for generic drugs. CMS names the drug for 134 of them, across 5 drugs with 11 or more claims each, at $2,877 in total drug cost. In 2023, CMS named 125 claims across 6 drugs.

Dr. Biro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 108 procedures of melanoma (skin cancer) excision by Dr. Biro, more than 94% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Biro, published from 2019 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Anxiety, Mohs Surgery and Skin Neoplasms. Dr. Biro has published most often in Dermatol Surg. Dr. Biro's most frequent co-authors are Min Deng, MD, Jeffrey F. Scott, MD and Michael Andrew Cardis, MD.

CMS Open Payments shows 10 general payments to Dr. Biro from 7 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $207. It also lists 9 research payments totaling $1,130 from 2024 to 2025, naming 1 clinical trial.